Healon
FDA Approves Dotarem, a New MRI Agent »
"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
Healon
Healon Side Effects Center
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Healon FDA Prescribing Information: Side Effects
(Adverse Reactions)
SIDE EFFECTS
Healon (sodium hyaluronate) is extremely well tolerated after injection into human eyes. A transient rise of intraocular pressure postoperatively has been reported in some cases.
In posterior segment surgery intraocular pressure rises have been reported in some patients, especially in aphakic diabetics, after injection of large amounts of Healon (sodium hyaluronate) .
Rarely, postoperative inflammatory reactions liritis, hypopyon as well as incidents of corneal edema and corneal decompensation have been reported. Their relationship to Healon (sodium hyaluronate) has not been established.
Read the entire FDA prescribing information for Healon (Sodium Hyaluronate) »
Additional Healon Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
